Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vivus: into single digits -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (525)	6/9/1998 8:19:00 PM
From: Mkilloran	Respond to of 1016

Vlad and Mike....don't want any patient to die from overexertion using Viagra or Muse. The trick is for the DR's to not recommend ANYTHING to a patient that may die due to overexertion period.... Dr's and patients will be more carefull not to mix Nitrates with Viagra....that subset of patients should be directed to MUSE. Diabetes patients and known patients with certain eye conditions should be directed to use Muse and not Viagra. Patients that do not succeed with Viagra should be directed to use MUSE. These are the groups that will get Vivus a slice of the bigger ED pie... Now how big a slice will this be??? That's the thing that we'er betting money on...as well as the future products that Vivus is working on "ALIBRA"...incontence med, pre-mature ejeculation med. etc..,etc... In for the long haul...not in this to daytrade and guess what price will be tommorow or next Tuesday.... I'll buy more on thw way up as the trend changes in favor of the bulls...it's way oversold now...may be more oversold tommorow... sowhat....if I buy more at 10 and it goes to 20 and sleep at night that's better for me,